Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization

Prostate

Volumn 46, Issue 3, 2001, Pages 184-190

  El Gedaily, Ahmed ^a   Bubendorf, Lukas ^a   Willi, Niels ^a   Fu, Wenting ^a   Richter, Jan ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Sauter, Guido ^a   Gasser, Thomas C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Amplification; CGH; Genetic; Hormone refractory; Prostate cancer

Indexed keywords

DNA;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 8Q; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; DISEASE PROGRESSION; DNA, NEOPLASM; GENE AMPLIFICATION; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROSTATIC NEOPLASMS;

EID: 0035130569     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20010215)46:3<184::AID-PROS1022>3.0.CO;2-8     Document Type: Article

References (44)

1. Annual report to the nation on the status of cancer 1973-1996, with a special section on lung cancer and tobacco smoking
2. Novel therapies for advanced prostate cancer
3. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
4. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
5. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
6. A similar pattern of chromosomal alterations in prostate cancers from African Americans and Caucasian Americans
7. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
8. Genetic alterations in hormone-refractory recurrent prostate carcinomas
9. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer
10. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization
11. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
12. Comparative genomic hybridization: A rapid new method for detecting and mapping DNA amplification in tumors
13. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
14. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
15. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
16. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridisation on tissue microarrays
17. Gene amplifications in advanced-stage human prostate cancer
18. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer
19. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma
20. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3
21. Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer
22. Molecular cytogenetic analysis of 11 new breast cancer cell lines
23. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
24. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas
25. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas
26. Interfocal heterogeneity of PTEN/ MMAC1 gene alterations in multiple metastatic prostate cancer tissues
27. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts
28. Genetic alterations in primary bladder cancers and their metastases
29. Dutrillaux B: Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique
30. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas
31. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features
32. Molecular cytogenetics of primary breast cancer by CGH
33. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization
34. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer
35. Comparison of genetic changes in primary sarcomas and their pulmonary metastases
36. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
37. DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcoma
38. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis
39. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer
40. Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors
41. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma
42. Expression profiling using cDNA microarrays
43. Tissue microarrays for high-throughput molecular profiling of tumor specimens